Ethics and transparency
Building trust through the way we work
We want to be valued not only for our medicines, but also for the way we work. We will lead our industry in demonstrating ethical business practices and applying high levels of integrity to everything we do. We apply consistently high standards of ethical practice and scientific conduct throughout our business and supply chain.
of active employees trained in code of ethics
Patient Partnership Programme
worth of counterfeit and illegal medicines seized
At AstraZeneca, we operate in a transparent and ethical way and expect the same high standards from our suppliers and partners. Whether it’s investing in technological alternatives to animals in science for our research or refusing to tolerate bribery or any other form of corruption, we go above and beyond what is required of us to be an example of how good business is done.
We prioritise the eight sustainability issues identified by our materiality assessment: setting strong anti-bribery and anti-corruption controls, ensuring ethical sales and marketing, the way we interact with patients, transparency of our clinical trials, our approach to bioethics, research with animals, ethically managing our supply chain, and having product security controls to deter counterfeiting.
Our professional interactions are transparent
By providing visibility into the details of financial arrangements with HCPs and HCOs, AstraZeneca hopes to foster a greater understanding of the value, appropriateness, and necessity of relationships between the pharmaceutical industry and HCPs and HCOs – relationships critical to the research and development of new medicines and to vital exchanges of information within the broader medical community. For more information as well as a view of our disclosure reports, click on the link below:
Image source: http://www.understandinganimalresearch.org.uk/resources/image-library